Lincomycin hydrochloride monohydrate,
7179-49-9,
Lincomycin hydrochloride hydrate,
LINCOMYCIN HCL,
CCRIS 9080,
Lincomycin, hydrochloride hydrate,
Lincomycin (hydrochloride hydrate),
UNII-M6T05Z2B68,
Mycivin,
NSC 70731,
M6T05Z2B68,
Methyl 6,8-dideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-D-erythro-alpha-D-galacto-octopyranoside monohydrochloride monohydrate,
Lincomycin soluble,
D-erythro-alpha-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, monohydrochloride, monohydrate, (2S-trans)-,
D-erythro-D-galacto-Octapyranoside, methyl 6,8-dideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, monohydrochloride, monohydrate, trans-alpha-,
C18H37ClN2O7S,
lincomycin hyalate,
C18H34N2O6S.ClH.H2O,
Lincocin (TN),
(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrate;hydrochloride,
Lincomycin hydrochloride [USP:JAN],
Lincomycin hydrochloride [USAN:JAN],
MFCD00167245,
SureCN721610,
AC1L2G8D,
SCHEMBL192963,
AC1Q3E14,
154-21-2 (Parent),
CHEMBL3989551,
LFZGYTBWUHCAKF-DCNJEFSFSA-N,
lincomycin-hydrochloride-monohydrate,
HY-B1358,
Lincomycin hydrochloride, monohydrate,
2516AH,
AKOS015896677,
API0007268,
CS-4856,
DS-3276,
Lincomycin Monohydrochloride, Hemihydrate,
LS-98138,
AX8136368,
FT-0630364,
Lincomycin hydrochloride hydrate (JP17/USP),
C14002,
D02346,
179L499,
C-22393,
I06-2232,
Lincomycin hydrochloride monohydrate, VETRANAL(TM), analytical standard,
Lincomycin hydrochloride, European Pharmacopoeia (EP) Reference Standard,
Lincomycin Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material,
Lincomycin hydrochloride, United States Pharmacopeia (USP) Reference Standard,
(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide hydrate hydrochloride,
D-erythro-alpha-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-, monohydrochloride, monohydrate,
D-erythro-D-Galacto-octopyranoside, methyl 6,8-dideoxy-6-(1-methyl-4-propyl-2-pyrrolidinecarboxamido)-1-thio-, monohydrochloride, hemihydrate,
Lincomycin hydrochloride for system suitability, European Pharmacopoeia (EP) Reference Standard,
Lincocin,
Lincomix,
hydrate,
hydrochloride,
lincomycin,
Lincomycin hydrochloride,
Lincocin Hydrochloride,
C18H34N2O6S,
CID71476,
AR-1J6936,
C18-H34-N2-O6-S.Cl-H.H2-O,
Lincomycin hydrochloride monohydrate, 98%, a narrow-spectrum antibiotic - 1G 1g,
(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide,
74515-47-2,
D-erythro-.alpha.-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-, monohydrochloride, monohydrate, (2S-trans)-,
D-erythro-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, monohydrochloride, monohydrate,trans- .alpha.-,
LCM,